Pronia Medical Systems

Pronia Medical Systems develops GlucoCare, an FDA-cleared insulin dosing calculator software designed for critical care settings. GlucoCare is a web-based medical device that runs on standard browsers within hospital intranets or via cloud deployment, requiring minimal IT infrastructure for installation. The system implements the Yale Protocol—a customized, patient-response-based insulin dosing algorithm that accounts for current blood glucose, prior glucose trends, measurement intervals, and current insulin rate to calculate real-time insulin resistance and recommend safe dose adjustments. Clinical evidence demonstrates GlucoCare achieves hypoglycemia rates below 0.2% for readings <70 mg/dL while maintaining target glucose ranges. The platform supports multiple protocol variants (GlucoCare-140, GlucoCare-160) with configurable target ranges (100–160 mg/dL) and allows clinician overrides with quality assurance documentation. Built-in analytics provide unit-level and individual-user tracking for glucose control compliance and protocol adherence, enabling continuous quality improvement. GlucoCare integrates with hospital EMR systems and has been validated in peer-reviewed literature (Diabetes, Technology and Therapeutics). The company partners with EHR platforms including Cerner-based systems. Intended users are primarily nurses and critical care teams in hospital ICU settings managing patients requiring insulin infusions.